Flu vaccine

The National Institutes of Health (NIH) has launched a Phase I clinical trial for a potential universal flu vaccine.   The trial will assess the vaccine candidate BPL-1357 which has been developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID). The candidate is a whole-virus vaccine made up of four strains of […]